Browsing: Therapy

Shares of Sangamo Therapeutics rose significantly, up to 36%, following the announcement that pharmaceutical giant Roche has halted its gene…

By Christy Santhosh and Unnamalai L (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers (NYSE:) Squibb’s combination…

Investing.com – Zarephath Therapeutics (NASDAQ:), a pioneer in precision genetic medicine for rare diseases, rose sharply after the market opened…